home / stock / mtem / mtem news

MTEM News and Press, Molecular Templates Inc.

Stock Information
Company Name: Molecular Templates Inc.
Stock Symbol: MTEM
Market: NASDAQ
Website: mtem.com
Menu
MTEM MTEM Quote MTEM Short MTEM News MTEM Articles MTEM Message Board
Get MTEM Alerts

News, Short Squeeze, Breakout and More Instantly...
MTEM - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2024-05-30 07:47:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning! Moving stocks this morning are earnings reports, new con...
MTEM - Molecular Templates GAAP EPS of $0.08, revenue of $11.09M beats by $5.19M

2024-05-15 17:46:50 ET More on Molecular Templates Molecular Templates announces $9.5M private placement offering Seeking Alpha’s Quant Rating on Molecular Templates Historical earnings data for Molecular Templates Financial information for Molecular T...

MTEM - Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update

AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineere...

MTEM - Molecular Templates files to sell 11.01M common shares for holders

2024-04-25 16:52:50 ET More on Molecular Templates Molecular Templates announces $9.5M private placement offering Seeking Alpha’s Quant Rating on Molecular Templates Read the full article on Seeking Alpha For further details see: Molecular Template...
MTEM - MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023

2024-04-11 13:52:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Molecular Templates (NASDAQ: MTEM ) just reported results for the fourth quarter of 2023. Molecular Templates reported earnings per share of -73 cents. This was above the ...

MTEM - Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers

2024-04-09 10:00:07 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...

MTEM - Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patie

AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, enginee...
MTEM - Molecular Templates GAAP EPS of -$0.73, revenue of $7.02M

2024-03-29 08:35:57 ET More on Molecular Templates Molecular Templates announces $9.5M private placement offering Seeking Alpha’s Quant Rating on Molecular Templates Historical earnings data for Molecular Templates Financial information for Molecular T...

MTEM - Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, enginee...

MTEM - Molecular Templates announces $9.5M private placement offering

2024-03-28 09:04:08 ET More on Molecular Templates Seeking Alpha’s Quant Rating on Molecular Templates Historical earnings data for Molecular Templates Financial information for Molecular Templates Read the full article on Seeking Alpha For fur...
Next 10